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WE sought to establish a model of inflammatory bowel
disease by augmenting the activity of the local immune
system with Freund’s complete adjuvant, and to deter-
mine ifinducible nitric oxide synthase (iNOS) expression
and peroxynitrite formation accompanied the inflamma-
tory condition. In anaesthetized guinea-pigs, a loop of
distal Heum received intraluminal 50% ethanol followed
by Freund’s complete adjuvant. Control animals were
sham operated. When the animals were killed 7 or 14
days later, loop lavage fluid was examined for nitrite and
PGE levels; mucosal levels of granulocyte and
macrophages were estimated by myeloperoxidase (MPO)
and N-acetyl-D-glucosaminidase (NAG) activity, respec-
tively. Cellular localization if iNOS and peroxynitrite for-
mation were determined by immunohistochemistry with
polyclonal antibodies directed against peptide epitopes of
mouse iNOS and nitrotyrosine, respectfully. Adjuvant
administration resulted in a persistent ileitis, featuring
gut thickening, crypt hyperplasia, villus tip swelling and
disruption, and cellular infiltration. Lavage levels ofPGE2
and nitrite were markedly elevated by adjuvant treat-
ment. Immunoreactive tNOS and nitrotyrosine bordered
on detectability in normal animals but were markedly
evident with adjuvant treatment at day 7 and particularly
day 14. Immunohistochemistry suggested that enteric
neurons and epithelia were major sites of iNOS activity
and peroxynitrite formation. We conclude that local ad-
ministration of adjuvant establishes a chronic ileitis. In-
ducible nitric oxide synthase may contribute to the in-
flammatory process.
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Introduction
Advances in our understanding of the
pathophysiology of inflammatory bowel disease and
potential therapeutic approaches to its management,
require animal models that mimic the human condi-
tion. While the currently used models have proved to
be useful and can predict the utility of current
pharmacotherapies, it is still widely recognized that
additional models are needed, particularly chronic
models. Hyperactivity of the gut-associated immune
system is a hallmark of inflammatory bowel disease,
although the triggers and factors maintaining this
state are multiple and complex. Activation of immune
defences with Freund’s complete adjuvant (FCA), has
been utilized in models of arthritis, a common sys-
temic complication associated with inflammatory
bowel disease, but we are aware of only one report
using this approach in gut inflammation. 3,4 Within
this conceptual framework we attempted to establish
a model of inflammatory bowel disease using FCA.
The ileum and guinea-pig were chosen as the target
organ and species, because of our previous experi-
ence with the trinitrobenzene sulphonic acid (TNBS)
model.
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It has recently been demonstrated that in contrast
to reports demonstrating that nitric oxide is protec-
tive in acute models of gut injury, 5,6 nitric oxide
synthase (NOS) inhibitors afford remarkable protec-
tive effects in chronic models of gut inflammation.
This apparent anomaly was termed the ’Jekyll and
Hyde’ role of nitric oxide in gut inflammation. The
reasons for this discrepancy appear to lie in the
enzyme source of nitric oxide; injury appears to be
associated with the inducible form of NOS (iNOS).9’1
In human inflammatory bowel disease, nitric oxide
production is exaggerated, with iNOS implicated as
the source of NO. 11’12 In order to evaluate the poten-
tial role of NO in this new model of inflammatory
bowel disease, we determined the magnitude of NO
production, the cellular localization of iNOS expres-
sion and peroxynitrite formation by immunohisto-
chemistry, the latter via the nitration of tyrosine
residues.
Materials and Methods
Animals: Fasted Hartley guinea-pigs of either sex
(250-450 g) were anaesthetized by intramuscular
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injection of ketamine (40 mg/kg), xylazine (10 mg/
kg) and atropine (0.2 mg/kg) supplemented with
inhaled methoxyflurane as required. Under aseptic
surgical conditions a midline laparotomy was per-
formed. The distal ileum was isolated and gently
flushed with intraluminal saline (2 ml) to remove
residual enteric contents. Ethanol (50%, 0.5 ml)was
injected transmurally into the lumen with a 26-gauge
needle in order to disrupt the epithelial barrier. After
5 min the ethanol was gently manipulated distally
and FCA (2 ml) was injected into the same site as
ethanol. The FCA was held in place for 30 min in a
5 cm loop with a polyethylene tubing before the
peritoneal cavity was closed by suturing layer by
layer. The guinea-pig was transferred to a warm
waterbed for post-operative recovery. Extensive pilot
experiments in which FCA was evaluated by direct
intramural injection and the ethanol/FCA volumes
were varied, were performed before the current ap-
proach was determined to be the easiest and most
reliable means of initiating gut inflammation. Sham
animals received the same surgical procedure but
saline, instead of ethanol and FCA, was injected into
the intestinal lumen.
After 7 or 14 days the guinea-pigs were anaesthe-
tized as described above. After flushing the ileal
contents with warm saline, a 10 cm loop of ileum
encompassing the region FCA administration, was
made with silk ligatures. Saline (3 ml) was injected
into the loop and after 30 min the loop was removed
from the animal and the loop fluid volume recorded.
The contents were centrifuged, divided into aliquots
and frozen. Ileal thickness was determined from the
ratio of weight to length; tissue water content and
sections were collected for MPO and NAG (E.C.
3.2.1.30) content and fixation for routine histology
and immunohistochemistry. Before the animals were
killed by anaesthesia overdose, cardiac blood was
drawn for quantification of peripheral leukocyte
counts. All protocols were reviewed and approved
by the institutional animal care and use committee,
following NIH guidelines and in accordance with the
Declaration of Helsinki.
Ileal lavage analysis: Loop fluid from ileal lavages
were analysed for levels of reactive nitrogen interme-
diates (nitrite/nitrate) as an index of local production
of NO, using a spectrophotometric technique as
described previously. Two methods were used: the
Griess reaction or the fluorometric assay described
by Misko and colleagues,1 after conversion of nitrate
to nitrite with bacterial-derived nitrate reductase
(Sigma Chemical Co., St Louis, MO). While the two
methods gave quantitatively different results the
trends associated with treatments were comparable.
Therefore, the Griess reaction results are shown and
not the fluorometric assay results, because the Griess
reaction is more widely used. In addition another
inflammatory mediator was quantified in the loop
fluid, prostaglandin E (POE2) using an ELISA kit
purchased from Cayman Chemical Company (Ann
Arbor, MI). A Bio-Rad model 3550 plate reader was
used for the Griess reaction and ELISA assays.
Cellular infiltration: Ileal MPO content was used as
an index of tissue granulocyte content as described
previously.TM Briefly, ileal mucosal scrapings
(100-250 mg) were finely minced at 4C, homo-
genized with a Brinkman polytron for 20 s in 50 mM
hexadecyltrimethylammonium bromide to inhibit the
pseudoperoxidase activity of haemoglobin. The
homogenate was centrifuged at 20 000 xg for 20 min
at 4C and the pellet was then frozen and thawed.
This cycle of homogenization, freezing and thawing
was repeated twice. Finally, an aliquot (100 t.tl) of
the supernatant was added to 2.9 ml of potassium
phosphate buffer (50 mM, pH 6.0) containing
o-dianisidine dihydrochloride (0.167 mg/ml) and
hydrogen peroxide (0.0005%). A Beckman DU-64
spectrophotometer was used to measure the absorb-
ance at 460 nm over 2 min. One unit ofMPO activity
was set at that which degraded 1 mol of H202 per
min at 25C.
Macrophage content in the ileum was estimated by
NAG activity15 in an analogous manner to the MPO
assay for granulocytes. The NAG content was re-
leased from gut tissue by the same homogenizing
and freeze-thawing procedure used for MPO. Assays
were done in 96-well microtitre plates, 10 1 of
sample or enzyme standard (Boehringer-Mannheim)
were added together with 2.5 l/well of substrate
(p-nitrophenyl-2-acetamide-2-deoxy-)-gluco
pyranoside, 2.24 mM Calbiochem, Ann Arbor, MI)
and 100 btl/well of citrate buffer (50 mM, pH 4.5).
Incubation was at room temperature for 60 min on a
rotamixer (Barnstead Thermolyn type 51300). The
reaction was stopped with a glycine buffer (100 }.tl,
200mM). The yellow coloured product (p-
nitrophenol) was read at 405 nm on a BioRad
microtitre plate reader (model 3550).
Circulating leukocyte counts were performed from
blood drawn by cardiac puncture. Blood (20 }.tl)was
mixed with 180 btl of 3% acetic acid. White blood
cells were counted using a Neubauer chamber under
light microscopy.
Morphometry: Tissue was fixed in Bouin’s solution
and embedded in paraffin for staining with Masson’s
trichrome stain for collagen, or alternatively, with
haematoxylin and eosin for routine histology.
Immunohistochemical detection of iNOS was done
in frozen tissue sections (5-10 l.tm) fixed with 1%
formaldehyde. Vectastain Elite ABC kits from Vector
Labs (Burlingame, CA) were used with a DAB
substrate for identification and haematoxylin as a
background stain. Antisera for nitrotyrosine was pro-
vided by Drs Joseph S. Beckman and Yao Zu Ye of
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the University of Alabama in Birmingham, USA. Tis-
sue thickness was determined from the ratio of
weight to length (mg/cm). Ileal water content was
determined from the wet to dry weight ratios.
Statistical analysis: All data is expressed as the mean
+ standard error. Groups were compared by analysis
of variance and where valid, a Bonferroni-adjusted t-
test was used to determine differences between in-
dividual groups. Kruskal-Wallis non-parametric tests
were used for variations between more than two
groups. Tests between groups used either Dunn’s
multiple comparison test or Tukey-Kramer multiple
comparison test. The software package Instat was
used to determine if tests were appropriate in addi-
tion to performing the analysis.
Results
Circulating and local leukocyte responses: Ileal MPO
content was markedly elevated at day 7 post-FCA
administration, and then declined towards basal lev-
els at day 14 (Table 1). NAG content remained above
control values at both days (p < 0.05), but was mark-
edly elevated at day 14. Total circulating leukocyte
counts were elevated with FCA administration in a
progressive manner over the 14 day study period
(Table 1).
Morphology and loop fluid analysis: Loop lavage
analysis revealed that FCA treated guinea-pigs had
elevated local production of nitric oxide (as deter-
mined by nitrite) and PGE at day 14 only (Table 2).
Nitrite levels were determined by the Griess reaction
or a fluorometric assay with comparable results (r
0.995). Ileal weight (mg/cm) was marginally in-
creased in response to FCA treatment over the course
of study (Table 2).
Table 1. Cellular responses in FCA-induced ileitis
Group Circulating Ileal Ileal
leukocyte MPO activity NAG activity
(cells/mma) (U/100 mg) (U/100 mg)
Control 3109 + 215 15.3 + 12.2 91.0 + 14.8
FCA 7 days 5384 + 646** 95.2 +/- 36.6** 112.4 +/- 18.1
FCA 14 days 5954 +/- 616"* 41.8 +/- 8.3* 409.4 + 18.6"’1.
Data expressed as mean +/- S.E.M. *p < 0.05 vs. control. **p < 0.01
vs. control. 1.p < 0.01 vs. FCA days.
Table 2. Ileal responses to FCA administration
Group Ileal weight Lavage fluid Lavage fluid
(mg/cm) nitrite PGE
(M) (ng/ml)
Control 72 + 6 8.1 +/- 1.2 0.47 +/- 0.08
FCA 7 days 83 +/- 3 48.3 +/- 10.8"* 0.30 +/- 0.06
FCA 14 days 85 +/- 3* 45.7 +/- 0.8** 1.50 +/- 0.30"1.
Data expressed as mean +/- S.E.M. Nitrite values determined by the
Griess reaction. *p < 0.05 vs. control. 1 P < 0.05 vs. FCA 7 days.
**p < 0.01 vs. control.
Histologically there was an increase in the extent
of tissue injury from day 7 to 14. At both time-points
there was a marked swelling of villus tips, with the
epithelia becoming detached from the underlying
basement membrane and rupturing (Fig. 1). Villus
tips contained a large number of macrophages with
vacuoles of cellular debris; macrophage accumula-
tion on the basal surface of the detached epithelia
was a common finding. The macrophages accumulat-
ing at the villus tips had a foamy appearance which
presumably resulted from the ingestion of mineral oil
in the adjuvant present in the mucosa.
Unlike the TNBS model in guinea pig ileum, FCA
ileitis was associated with crypt abcesses (Fig. 1);
these abcesses contained primarily macrophages and
lymphocytes. In some sections it was evident that
inflammatory cells extended from crypt abcesses
between villi towards the lumen of the ileum. A
marked hypercellularity of the crypts and absence of
goblet cells was readily noted (Fig. 1). There was
only minimal evidence of the inflammatory process
in the muscularis; cellular infiltration appeared to be
confined to the mucosa. Only a slight deposition of
collagen in the submucosa was evident.
In normal guinea-pigs there was minimal positive
staining for iNOS immunoreactivity. However, in the
FCA-induced ileitis iNOS positive staining was evi-
dent in epithelia, particularly in terminal enterocytes
and neurons in the submucosal and myenteric plex-
uses (Fig. 2). Nitrotyrosine immunoreactivity was
located in the same sites as iNOS, being most evident
in epithelia and myenteric neurons (Fig. 2). Incuba-
tion of the antibody with exogenous nitrotyrosine
abolished the staining, indicating that positive stain-
ing was specific for nitrotyrosine present in the
tissue.
Discussion
Local administration of FCA initiates an inflamma-
tory response in the guinea-pig ileum which is
chronic in nature. Indices of gut injury and inflamma-
tion appear to be worse at day 14 compared with the
appearance at day 7, with the exception of MPO
activity. The diminished granulocyte content as de-
termined by the MPO assay, probably reflects a
change in the infiltrating cell type from granulocytes
to macrophages and lymphocytes, as indicated in
histological sections and by the NAG assay.
This approach to modelling inflammatory bowel
disease, initially reported by Yamada et al. has great
potential.,4 Yamada and colleagues reported that
both complete and incomplete adjuvant could estab-
lish colitis in rats when administered directly into the
bowel wall. The present approach using luminally
applied adjuvant after epithelial exposure to a barrier
breaker (ethanol) yielded similar results. Systemic
levels of nitric oxide (nitrite/nitrate) were elevated in
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FIG. 1. Light photomicrographs of villus tips (Panel a) of adjuvant ileitis in
guinea-pigs (original magnification x 200, haematoxylin and eosin staining).
In Panel (a), the villus tip is swollen with detachment of the epithelia from
the basement membrane. The lamina propria is rich in macrophages. In
Panel (b), hyperplasia of the crypt epithelia is evident together with cellular
infiltration (lymphocytes and macrophages) and a paucity of goblet cells.
the rat model of adjuvant colitis,3,4 as has been
demonstrated in adjuvant-induced models of arthri-
tis. 16,17 Activation of local nitric oxide production was
also observed in this study in guinea-pig ileitis.
However, does the current model accurately reflect
events seen in human inflammatory bowel disease?
Firstly, our model, established in the ileum, may be
better suited as model of ulcerative colitis rather than
Crohn’s disease. Several observations led to this
conclusion. The cellular infiltrate was largely con-
fined to the mucosa and the crypt abcesses and
epithelial disruption may better reflect ulcerative
colitis than Crohn’s disease. On the other hand the
predominance of macrophages in the villus tips,
particularly underlying detached epithelia at day 14,
appears to be a unique feature and is not necessarily
representative of any singular form of gut inflamma-
tion. It could serve as a useful model of macrophage-
mediated injury. We have extensive experience with
the TNBS model in the same species/site, and the
FCA model appears to be less severe. Its distinguish-
ing features are a relative lack of neutrophils but high
numbers of macrophages and lymphocytes. Never-
theless, both models demonstrate an expression of
iNOS. The advantage of the FCA model over the
TNBS model, is that there is little damage or inflam-
mation during the first week; rather, inflammation is
established in the second week after a lag period. In
FIG. 2. Immunohistochemistry for iNOS and nitrotyrosine in terminal epithelia (Panels a and b respectively) and myenteric ganglia (Panels c and
d respectively) of a guinea-pig 14 days after treatment with FCA. The DAB peroxidase method was used to visualize iNOS or nitrotyrosine; positive
staining is indicated by a brown colour over the blue counterstaining of haematoxylin. Positive staining for both iNOS and nitrotyrosine was intense
in epithelial cells and neurons of the myenteric plexus.
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this regard it resembles the time course of adjuvant
arthritis.
The FCA model that we have developed bears
promise in that it is easy to initiate. Activation of the
local immune system reflects the human condition
where no single or primary pathogen is required,
there are systemic consequences and the model is
chronic. One may anticipate that reactivation of im-
munity by additional challenges, may prolong or
reactivate this model of gut inflammation. Luminal
application of FCA was chosen rather than the direct,
subserosal approach of Yamada et al. because in our
hands it is technically easier and more reliable. 3,4 It is
particularly difficult to administer agents into the gut
wall of small animals. Often the agent is administered
into the lumen or on the serosal surface, where
it could cause a peritonitis. With the use of ethanol
as a barrier breaker, as previously described for
the TNBS model, we avoid these complications
but still manage to introduce the adjuvant into
the mucosal tissue. 18,19 Injury induced by ethanol
alone, 0.5 ml transmurally into the ileal lumen, is
fully resolved by day 3,19 and does not directly
influence the interpretation of the data obtained
at days 7 or 14. In pilot experiments to evaluate
the model, no injury was found after a transmural
injection of FCA alone.
An additional goal of the study was to determine
if nitric oxide synthesized by the inducible form of
NOS, contributed to tissue injury in this model. As
previously noted in the TNSB model of ileitis,
FCA-induced inflammation is associated with an up-
regulation of nitric oxide production. This appears
to be the result of iNOS gene expression, with novel
sites of induced NO production. The role of iNOS
in this inflammatory response was evaluated with
immunohistochemical techniques. It was observed
that iNOS immunoreactivity was negligible or absent
in normal controls but quite evident in FCA ileitis.
Staining for iNOS was particularly intense in
epithelial cells, predominantly mature enterocytes
as there was little staining in crypt cells. Positive
staining for iNOS was also observed in enteric neu-
rons, both myenteric and submucosal. Again this was
in response to the inflammatory state because iNOS
staining was not apparent in normal controls. Expres-
sion of iNOS was associated with the formation
of peroxynitrite, as indicated by nitrotyrosine
immunoreactivity.’ Nitric oxide itself cannot form
nitrotyrosine, nitration of tyrosine involves NO2+ a
degradation product of peroxynitrite (ONOO-) or its
protonated form which dominates at physiological
pH. Peroxynitrite formation is normally associated
with cell injury, suggesting that sites of iNOS expres-
sion are sites of cell injury or toxicity.
The expression of iNOS in epithelial cells may be
interpreted as a defensive mechanism against invad-
ing microbes, with the production of a toxic chemical
barrier. This response is persistent in the FCA model
due to the continued presence of adjuvant (which
contains mineral oil and dead mycobacteria) within
the mucosa, possibly leading to enterocyte injury and
increased cell turnover.
The presence of iNOS in enteric neurons is slightly
more puzzling. Certainly dysmotility is a hallmark of
gut inflammation but the nature or presence of al-
tered gut motility is yet to be explored in this model.
Neuronal cell injury due to excessive release of nitric
oxide has been better explored in the central nervous
system. As far as the authors are aware, those features
described in the CNS, calcium overload in conjunc-
tion with NMDA receptor activation,
21,’’ have not
been evaluated in the gut.
In summary, local administration of FCA into the
ileal mucosa establishes a chronic inflammation with
features that suggest it may be a useful model for
inflammatory bowel disease. As noted previously in
the TNBS model of ileitis, FCA-induced inflammation
initiates iNOS expression and excessive NO produc-
tion. In the gut, the epithelia and enteric neurons are
important sites of iNOS induction. Both the FCA
model and role of iNOS and peroxynitrite in inflam-
matory bowel disease appear to be worthy of future
investigation.
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